InvestorsHub Logo
Followers 66
Posts 11443
Boards Moderated 0
Alias Born 10/20/2009

Re: djohn post# 233224

Wednesday, 09/02/2015 9:17:22 AM

Wednesday, September 02, 2015 9:17:22 AM

Post# of 345756
djohn...if I may...the tumor environment promotes the presence of MDSCs and stops the production of the mature Dendritic Cells. As in the PD-1 angle where there is ~25% ORR, the CD-47 looks like it may work but it will be limited because the Dendritic Cells are not present....of course, unless the patient is pre-treated with Bavituximab.

Phosphatidylserine IS the target to be manipulated.

Remember, I'm a Realtor... : )

wook

Best of $RESULTS for Humanity, FDA Approval(s), Partner(s) Production, Imaging and MOST IMPORTANTLY!!!
Research.
Always looking deeper. RIP Dr. Thorpe

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News